Filtered By:
Procedure: Anesthesia
Vaccination: Cancer Vaccines

This page shows you your search results in order of date.

Order by Relevance | Date

Total 17 results found since Jan 2013.

Weekly Overseas Health IT Links –1st October, 2022.
This article details information required for integration into EHRs to build personalized treatment plans and develop successful SDOH programs that provide resources and support for patients in need. In addition, successful SDOH programs implemented by Kaiser Permanente and Boston Medical Center showcase how supporting clinicians with real-time SDOH data can lead to patient-centric care. Create a 360-Degree Patient View Through TechnologyThe Office of the National Coordinator for Health Information Technology (ONC)indicatesthat the “collection, documentation, reporting, access, and use of SDOH data … can be used t...
Source: Australian Health Information Technology - October 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer
Urol Oncol. 2020 Oct 23:S1078-1439(20)30477-4. doi: 10.1016/j.urolonc.2020.10.004. Online ahead of print.ABSTRACTNon-muscle-invasive bladder cancer is one of the most common malignancies. Patients with intermediate-risk or high-risk disease can be treated with intravesical Bacillus Calmette-Guerin, a vaccine against tuberculosis. However, many of these patients will experience tumor recurrence, despite appropriate treatment. 1 The standard of care in these patients is radical cystectomy (RC) with urinary diversion. 2 Patients diagnosed with muscle-invasive bladder cancer (MIBC) have traditionally faced 2 main treatment opt...
Source: Urologic Oncology - November 10, 2021 Category: Urology & Nephrology Authors: Rosa Nadal Andrea B Apolo Daniel M Girardi Noah M Hahn Joaquim Bellmunt Source Type: research

Fight Aging! Newsletter, August 30th 2021
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out mo...
Source: Fight Aging! - August 29, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Endometrial Cytology as a Method to Improve the Accuracy of Diagnosis of Endometrial Cancer: Case Report and Meta-Analysis
Conclusion In conclusion, endometrial cytology is an efficient diagnostic method and could be applied in the diagnosis of endometrial disorders. The diagnostic accuracy of endometrial carcinoma will surely be improved by the combination of cyto-histopathological procedures and vaginal ultrasonography. Moreover, cytological examination, as a proper outpatient procedure, should be advised for endometrial screening, especial for those with high-risks of endometrial cancer. Author Contributions QingW and QiW drafted the manuscript. QingW, LZ, and CS collected the case. QiW, LH, and SM performed the meta analysis. HH perform...
Source: Frontiers in Oncology - April 23, 2019 Category: Cancer & Oncology Source Type: research

High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
In this study, the immunohistochemistry results demonstrated that DEPDC1 was high-expressed in breast cancer tissues compared with the paired adjacent normal breast tissues, and its tendency at protein level was consistent with mRNA level from TCGA data. Moreover, DEPDC1 mRNA level revealed the strongest association with poor prognosis and development in breast cancer. In vitro assays showed that DEPDC1 overexpression resulted in significant promotion of proliferation by regulating cell cycle in MCF-7 cells, whilst an opposite effect was found in the MDA-MB-231 cells with DEPDC1 deletion. Notably, further investigation ind...
Source: Frontiers in Oncology - April 11, 2019 Category: Cancer & Oncology Source Type: research

Tech Will Transform the Doctor-Patient Relationship
This article was originally published in the Health Service Journal — Jen Hyatt is founder and chief executive of Big White Wall and  a Disruptive Woman to Watch in 2014. 
Source: Disruptive Women in Health Care - July 21, 2014 Category: Consumer Health News Authors: DW Staff Tags: Access Advocacy HIT/Health Gaming Innovation Source Type: blogs